
References
Merians AN, Spiller T, Harpaz-Rotem I, Krystal JH, Pietrzak RH. Post-traumatic stress disorder. Med Clin N Am 2023, 107: 85–99.
Mastrodonato A, Pavlova I, Kee NC, Pham VA, McGowan JC, Mann JJ. Prophylactic (R, S)-ketamine is effective against stress-induced behaviors in adolescent but not aged mice. Int J Neuropsychopharmacol 2022, 25: 512–523.
Ma JH, Wang SY, Yu HY, Li DY, Luo SC, Zheng SS, et al. Prophylactic use of ketamine reduces postpartum depression in Chinese women undergoing cesarean section ✰. Psychiatry Res 2019, 279: 252–258.
Chen BK, Luna VM, LaGamma CT, Xu X, Deng SX, Suckow RF, et al. Sex-specific neurobiological actions of prophylactic (R, S)-ketamine, (2R, 6R)-hydroxynorketamine, and (2S, 6S)-hydroxynorketamine. Neuropsychopharmacology 2020, 45: 1545–1556.
Mastrodonato A, Jin M, Kee N, Lanio M, Tapia J, Quintana L, et al. Prophylactic (R, S)-ketamine and (2S, 6S)-hydroxynorketamine decrease fear expression by differentially modulating fear neural ensembles. Biol Psychiatry 2024, S0006–3223(24): 01649–01654.
Pastuzyn ED, Day CE, Kearns RB, Kyrke-Smith M, Taibi AV, McCormick J, et al. The neuronal gene arc encodes a repurposed retrotransposon gag protein that mediates intercellular RNA transfer. Cell 2018, 172: 275-288.e18.
Liu RJ, Ota KT, Dutheil S, Duman RS, Aghajanian GK. Ketamine strengthens CRF-activated amygdala inputs to basal dendrites in mPFC layer V pyramidal cells in the prelimbic but not infralimbic subregion, A key suppressor of stress responses. Neuropsychopharmacology 2015, 40: 2066–2075.
Vann SD, Aggleton JP, Maguire EA. What does the retrosplenial cortex do? Nat Rev Neurosci 2009, 10: 792–802.
Hess EM, Riggs LM, Michaelides M, Gould TD. Mechanisms of ketamine and its metabolites as antidepressants. Biochem Pharmacol 2022, 197: 114892.
Hare BD, Duman RS. Prefrontal cortex circuits in depression and anxiety: Contribution of discrete neuronal populations and target regions. Mol Psychiatry 2020, 25: 2742–2758.
Acknowledgements
This highlight article was supported by the National Natural Science Foundation of China (82104138) and the Zhejiang Provincial Natural Science Foundation of China (LY24H310003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, M., Cheng, L. Mapping Fear-Related Neural Activity and Circuitry Changes Following Prophylactic Administration of (R,S)-Ketamine and (2S,6S)-Hydroxynorketamine. Neurosci. Bull. 41, 925–928 (2025). https://doi.org/10.1007/s12264-025-01362-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12264-025-01362-y